Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2013 1
2015 1
2016 1
2017 1
2018 2
2019 3
2021 1
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.
Chaparro M, Acosta D, Rodríguez C, Mesonero F, Vicuña M, Barreiro-de Acosta M, Fernández-Clotet A, Hernández Martínez Á, Arroyo M, Vera I, Ruiz-Cerulla A, Sicilia B, Cabello Tapia MJ, Muñoz Villafranca C, Castro-Poceiro J, Martínez Cadilla J, Sierra-Ausín M, Vázquez Morón JM, Vicente Lidón R, Bermejo F, Royo V, Calafat M, González-Muñoza C, Leo Carnerero E, Manceñido Marcos N, Torrealba L, Alonso-Galán H, Benítez JM, Ber Nieto Y, Diz-Lois Palomares MT, García MJ, Muñoz JF, Armesto González EM, Calvet X, Hernández-Camba A, Madrigal Domínguez RE, Menchén L, Pérez Calle JL, Piqueras M, Dueñas Sadornil C, Botella B, Martínez-Pérez TJ, Ramos L, Rodríguez-Grau MC, San Miguel E, Fernández Forcelledo JL, Fradejas Salazar PM, García-Sepulcre M, Gutiérrez A, Llaó J, Sesé Abizanda E, Boscá-Watts M, Iyo E, Keco-Huerga A, Martínez Bonil C, Peña González E, Pérez-Galindo P, Varela P, Gisbert JP; To-ReWard Study Group. Chaparro M, et al. Among authors: munoz villafranca c. Am J Gastroenterol. 2023 Jul 1;118(7):1237-1247. doi: 10.14309/ajg.0000000000002145. Epub 2022 Dec 14. Am J Gastroenterol. 2023. PMID: 36716287
Extensive colitis associated with ixekizumab.
López García ML, Arreba González MP, Irusta Olano L, Muñoz Villafranca C. López García ML, et al. Among authors: munoz villafranca c. Rev Esp Enferm Dig. 2024 Apr 18. doi: 10.17235/reed.2024.10428/2024. Online ahead of print. Rev Esp Enferm Dig. 2024. PMID: 38634893 Free article.
Ustekinumab treatment for toxic megacolon in severe colonic Crohn's disease.
Irabien M, Arreba P, Ortiz de Zárate J, Hernández-Aretxabaleta N, de la Maza-Ortiz S, Ispizua-Madariaga N, Muñoz-Villafranca C. Irabien M, et al. Among authors: munoz villafranca c. Rev Esp Enferm Dig. 2021 Mar;113(3):189-192. doi: 10.17235/reed.2020.7228/2020. Rev Esp Enferm Dig. 2021. PMID: 33244975 Free article.
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients.
Gutiérrez A, Zapater P, Ricart E, González-Vivó M, Gordillo J, Olivares D, Vera I, Mañosa M, Gisbert JP, Aguas M, Sánchez-Rodríguez E, Bosca-Watts M, Laredo V, Camps B, Marín-Jiménez I, Zabana Y, Martín-Arranz MD, Muñoz R, Navarro M, Sierra E, Madero L, Vela M, Pérez-Calle JL, Sainz E, Calvet X, Arias L, Morales V, Bermejo F, Fernández-Salazar L, Van Domselaar M, De Castro L, Rodríguez C, Muñoz-Villafranca C, Lorente R, Rivero M, Iglesias E, Herreros B, Busquets D, Riera J, Martínez-Montiel MP, Roldón M, Roncero O, Hinojosa E, Sierra M, Barrio J, De Francisco R, Huguet J, Merino O, Carpio D, Ginard D, Muñoz F, Piqueras M, Almela P, Argüelles-Arias F, Alcaín G, Bujanda L, Manceñido N, Lucendo AJ, Varela P, Rodríguez-Lago I, Ramos L, Sempere L, Sesé E, Barreiro-de Acosta M, Domènech E, Francés R. Gutiérrez A, et al. Among authors: munoz villafranca c. Front Med (Lausanne). 2022 Feb 1;9:823900. doi: 10.3389/fmed.2022.823900. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35178413 Free PMC article.
Increased risk of thiopurine-related adverse events in elderly patients with IBD.
Calafat M, Mañosa M, Cañete F, Ricart E, Iglesias E, Calvo M, Rodríguez-Moranta F, Taxonera C, Nos P, Mesonero F, Martín-Arranz MD, Mínguez M, Gisbert JP, García-López S, de Francisco R, Gomollón F, Calvet X, Garcia-Planella E, Rivero M, Martínez-Cadilla J, Argüelles F, Arias L, Cimavilla M, Zabana Y, Domènech E; ENEIDA registry of GETECCU. Calafat M, et al. Aliment Pharmacol Ther. 2019 Oct;50(7):780-788. doi: 10.1111/apt.15458. Epub 2019 Aug 19. Aliment Pharmacol Ther. 2019. PMID: 31429097
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry.
Calafat M, Mañosa M, Ricart E, Nos P, Iglesias-Flores E, Vera I, López-Sanromán A, Guardiola J, Taxonera C, Mínguez M, Martín-Arranz MD, de Castro L, de Francisco R, Rivero M, Garcia-Planella E, Calvet X, García-López S, Márquez L, Gomollón F, Barrio J, Esteve M, Muñoz F, Gisbert JP, Gutiérrez A, Hinojosa J, Argüelles-Arias F, Busquets D, Bujanda L, Pérez-Calle JL, Sicilia B, Merino O, Martínez P, Bermejo F, Lorente R, Barreiro-de Acosta M, Rodríguez C, Fe García-Sepulcre M, Monfort D, Cañete F, Domènech E; ENEIDA Study Group of GETECCU. Calafat M, et al. J Crohns Colitis. 2022 Jul 14;16(6):946-953. doi: 10.1093/ecco-jcc/jjab213. J Crohns Colitis. 2022. PMID: 34864947
Adalimumab treatment of anti-TNF-naïve patients with ulcerative colitis: Deep remission and response factors.
Muñoz-Villafranca C, Ortiz de Zarate J, Arreba P, Higuera R, Gómez L, Ibáñez S, Merino O, Muñagorri A, Ogueta M, Rodriguez C, Nantes O, Ramirez de la Piscina P, Rodríguez I, Bernal A, Arévalo J, Cabriada J. Muñoz-Villafranca C, et al. Dig Liver Dis. 2018 Aug;50(8):812-819. doi: 10.1016/j.dld.2018.03.007. Epub 2018 Mar 14. Dig Liver Dis. 2018. PMID: 29625907
[Adalimumab vasculitis in a patient with Crohn's disease].
Muñoz Villafranca C, Izu Belloso RM, Bravo Rodriguez MT, Basterra Olabarrieta S. Muñoz Villafranca C, et al. Gastroenterol Hepatol. 2013 Apr;36(4):296-7. doi: 10.1016/j.gastrohep.2012.10.004. Epub 2013 Mar 22. Gastroenterol Hepatol. 2013. PMID: 23522950 Spanish. No abstract available.
Infliximab as treatment of severe enteropathy in a patient with common variable immunodeficiency and cytomegalovirus infection.
Prieto Elordui J, Arreba Gonzalez P, Ortiz de Zarate Sagastagoitia J, Deiss Pascual L, Blanco Sampascual S, Baranda Martín A, Calderón García A, Muñoz Villafranca C. Prieto Elordui J, et al. Among authors: munoz villafranca c. Gastroenterol Hepatol. 2018 Mar;41(3):163-164. doi: 10.1016/j.gastrohep.2017.03.002. Epub 2017 May 2. Gastroenterol Hepatol. 2018. PMID: 28476306 English, Spanish. No abstract available.
14 results